"The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of dalbavancin 500 mg (Xydalba, Durata Therapeutics) for acute bacterial skin and skin structure infections (ABSSSI) in ad"...
Firazyr Patient Information including How Should I Take
In this Article
- What is icatibant (Firazyr)?
- What are the possible side effects of icatibant (Firazyr)?
- What is the most important information I should know about icatibant (Firazyr)?
- What should I discuss with my healthcare provider before receiving icatibant (Firazyr)?
- How is icatibant given (Firazyr)?
- What happens if I miss a dose (Firazyr)?
- What happens if I overdose (Firazyr)?
- What should I avoid after receiving icatibant (Firazyr)?
- What other drugs will affect icatibant (Firazyr)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving icatibant (Firazyr)?
You should not use icatibant if you are allergic to it.
To make sure you can safely use icatibant, tell your doctor about all of your medical conditions.
FDA pregnancy category C. It is not known whether icatibant will harm an unborn baby. Tell your doctor if you are pregnant before using this medication.
It is not known whether icatibant passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How is icatibant given (Firazyr)?
Icatibant is injected under the skin. You will be shown how to use injections at home. Do not self inject this medicine if you do not fully understand how to give the injection and properly dispose of used needles and syringes.
Get emergency medical help if you have any swelling of your tongue or throat during an angioedema attack.
This medication comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.
Prepare your dose in a syringe only when you are ready to give yourself an injection. Do not use the medication if it looks cloudy or has particles in it. Call your doctor for a new prescription.
Wash your hands with soap and water before preparing your injection.
Do not give an injection into an area that is painful, swollen, or bruised.
If you still have symptoms of angioedema after the first injection, you may use another injection after at least 6 hours have passed.
Do not use more than 3 icatibant injections within a 24-hour period.
Call your doctor if your symptoms do not improve, or if they get worse after using this medication.
Each prefilled syringe of this medicine is for one use only. Throw away after one use, even if there is still some medicine left in it after injecting your dose.
Use a syringe and needle only once. Throw away used needles in a puncture-proof container (ask your pharmacist where you can get one and how to dispose of it). Keep this container out of the reach of children and pets.
Store icatibant in the original container at room temperature, away from moisture and heat.
You may also store this medicine in the refrigerator. Do not freeze.
Additional Firazyr Information
- Firazyr Drug Interactions Center: icatibant subq
- Firazyr Side Effects Center
- Firazyr FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.